Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. - Wikidata - wikimedia - TriplyDB

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.

http://www.wikidata.org/entity/Q34696246

about

A small-cell lung cancer genome with complex signatures of tobacco exposure Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?The well-accepted notion that gene amplification contributes to increased expression still remains, after all these years, a reasonable but unproven assumption Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer An overview of long non-coding RNAs in ovarian cancers Noncoding RNAs in DNA repair and genome integrity The Significance of Long Noncoding RNA H19 in Predicting Progression and Metastasis of Cancers: A Meta-Analysis MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.The Role of Long Non-Coding RNAs in Ovarian Cancer.Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Evaluation of the 8q24 prostate cancer risk locus and MYC expression.High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors.Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis.Identification of senescence-associated circular RNAs (SAC-RNAs) reveals senescence suppressor CircPVT1 Role of non-coding RNAs in maintaining primary airway smooth muscle cells Identification of candidate epigenetic biomarkers for ovarian cancer detection.Systematic mapping of functional enhancer-promoter connections with CRISPR interference.Genome profiling of ERBB2-amplified breast cancers.PVT1-derived miR-1207-5p promotes breast cancer cell growth by targeting STAT6.Upregulation of the long non-coding RNA PVT1 promotes esophageal squamous cell carcinoma progression by acting as a molecular sponge of miR-203 and LASP1 Dysregulated expression of long noncoding RNAs in gynecologic cancers.Genetic variants within the cancer susceptibility region 8q24 and ovarian cancer risk in Han Chinese women The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer.A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development.Copy number analysis identifies novel interactions between genomic loci in ovarian cancer A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy Emerging paradigms of long non-coding RNAs in gastrointestinal cancer.p27Kip1 mediates addiction of ovarian cancer cells to MYCC (c-MYC) and their dependence on MYC paralogs.Breast cancer genomes--form and function 8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia A transcriptome signature of endothelial lymphatic cells coexists with the chronic oxidative stress signature in radiation-induced post-radiotherapy breast angiosarcomas.Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer Functional annotation of colon cancer risk SNPs.Pan-cancer transcriptome analysis reveals long noncoding RNAs with conserved function.Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc.

P2860

Q24600510-D70604B6-85A6-42A1-9E5D-FC8C9CE942B5 Q26738706-4B5F410E-7BE0-42F3-9251-C79BCD7EADD2 Q26746180-DB844174-BDA7-4F61-BAE6-C20A2321D676 Q26752457-F0B7E68F-6932-48CC-ADCE-A4271B29D868 Q26753467-2301E06F-6B85-405C-B0F3-C7EDAB3744DA Q26864697-566F92FC-5678-4DA3-AED4-887E89E816EC Q28076788-9EC25755-986B-4CCE-A2F3-B138C8ADDD6A Q30244282-60FCDBF8-31C0-4BC5-9B3A-43E788BC3869 Q30245117-05CA2ECA-C864-4C2B-ACD7-B4E6B5399611 Q30252854-31DFF241-A17F-49B1-80EB-1764C5206A08 Q30494853-39E47C70-2B64-4CBD-A548-C015FB2B1F25 Q33440056-CECB971D-B542-41AB-A96C-1190F38EB793 Q33553289-DBF9DC5A-0180-472C-9C62-D0741A05DBF8 Q33580276-02834E20-C399-4F10-AC14-BAE38BC610E4 Q33690703-3F24253E-E1A3-482E-B1C0-64539BA43A20 Q33690825-B79E3505-522B-494D-89C3-4EB6130CD974 Q33709312-29DAAD3A-4397-4C28-997C-49AEF5EE3E74 Q33713239-9166CF7F-0317-4B49-B181-6DBAB775BF71 Q33738854-17DD7C35-62DA-4B5C-99E6-C9D6CAECE0A3 Q33798305-0CB99452-0E32-4945-8B49-72FAC946CD71 Q33823613-B07B24E3-443D-470B-B8F6-70787A537D3D Q33829530-F8CA1D84-BD81-4841-A861-0DFA2CA9DAA5 Q33848422-34041A38-10AC-4C90-B0B1-4127E8881A83 Q33883432-9797461C-01BA-4E79-8FF1-76AFB04B7231 Q33962806-FA53209A-4A17-4048-9B34-6B2E87D31C74 Q33981307-3E3BB969-8C59-40F7-8197-FBDDF8B12614 Q34091855-53C2DC0C-43AE-4BBC-AC90-C34ED7C109A8 Q34117394-C6E742C9-9993-4B5A-83C5-2EC6C07469FA Q34154720-DA23826F-4478-49DC-B8F3-3E8891B667E1 Q34178419-913F2187-D941-4045-AFF6-2BDD78D8865F Q34186642-FBDB1E2E-C3DC-4680-8C33-FC5EADA36896 Q34207688-6F40846C-AC02-45F9-A1AA-A11D9B2A1F3D Q34252299-6FAE9057-EDC2-43BA-9EA3-7380412D3688 Q34270766-FB70A2E1-F2ED-43ED-8CD0-4441F86891D5 Q34340593-B6A63DA3-22E0-4FDD-8590-809F04362A60 Q34345765-2CB50D4E-044D-4BA5-BF3E-25C3A6880FAA Q34357186-50388B46-ADDF-4C4B-96AB-4C8939402702 Q34471303-8A05A3AD-7E9F-4E25-B82A-ACFE7EAF0DF2 Q34501770-AFC1FA51-8343-4D60-B278-1119F0AB5ABA Q34558930-7CB1B33B-E44F-4853-BC3C-233173E14348

P2860

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.

http://www.wikidata.org/entity/Q34696246

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.

@ast

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.

@en

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.

@nl

type

label

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.

@ast

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.

@en

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.

@nl

prefLabel

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.

@ast

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.

@en

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.

@nl

P1433

Q34696246-5F5B7140-0224-4D93-8B82-7817994E2E9A

P1476

Q34696246-74E491FA-F1EA-41E4-BEB5-B8D6821BC7EC

P2093

Q34696246-03AFB912-0112-42A2-A070-4C160B19C161

Q34696246-223960F0-1D8D-478A-8F83-ACCF9A587A36

Q34696246-2F53AE99-FCAB-45F3-A96E-2904A18AEB5C

Q34696246-3491FD6A-2BA7-4062-BB0D-9AF7EACA722C

Q34696246-65217A31-5139-4199-910D-895986D12965

Q34696246-77F2D6A7-F368-409D-B340-A8BD1E74C6A9

Q34696246-83CFB6F7-403B-4D90-8FE2-B335D718B008

Q34696246-866AD6E6-7E1D-47EA-8E0D-103871CCFA58

Q34696246-9A16D347-2544-40E8-8337-78564494F18D

Q34696246-ABAC97F0-BD8F-4D90-96EB-D0D39EEBB574

P304

Q34696246-EE06D6D4-107D-4A3D-B65D-F7FDA092EC30

P31

Q34696246-4BBC4D33-DB42-4687-BF3C-52D01BB5AB52

P356

Q34696246-FCE72C14-4351-4650-833D-C8E859EBE398

P407

Q34696246-69EE53AF-CF25-48D5-BFAA-53963C57636D

P433

Q34696246-3CE85E71-DAEF-45AE-97F4-F4131288A5FF

P478

Q34696246-30D27E0C-C45E-47E1-9268-E37D828C0F23

P50

Q34696246-30D75206-CAB4-481E-A4CE-EE702226B124

P577

Q34696246-103ECBFD-A9FC-4C39-80CC-9B2F3DAD8AA6

P698

Q34696246-9B041FF3-210A-4EA5-A38A-1E01EA6AA4B1

P921

Q34696246-72B3250D-0256-4DB3-B90A-754CC51DA0A0

P356

1078-0432.CCR-06-2882

P1433

Clinical Cancer Research

P1476

Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer

@en

P2093

Anna V Lapuk

http://www.w3.org/2001/XMLSchema#string

David G Ginzinger

http://www.w3.org/2001/XMLSchema#string

David G Huntsman

http://www.w3.org/2001/XMLSchema#string

Gordon B Mills

http://www.w3.org/2001/XMLSchema#string

Hirokuni Takano

http://www.w3.org/2001/XMLSchema#string

Jackie L Stilwell

http://www.w3.org/2001/XMLSchema#string

Jane Fridlyand

http://www.w3.org/2001/XMLSchema#string

Jennifer L Santos

http://www.w3.org/2001/XMLSchema#string

Joe W Gray

http://www.w3.org/2001/XMLSchema#string

Joseph W Carlson

http://www.w3.org/2001/XMLSchema#string

P304

5745-5755

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-06-2882

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17908964

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology